Modifiable Determinants of Satisfaction with Intravitreal Treatment in Patients with Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Modifiable Determinants of Satisfaction with Intravitreal Treatment in Patients with Neovascular Age-Related Macular Degeneration

Published:2022-04-29 Issue:5 Volume:39 Page:355-366
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs Aging

Author:

Calles-Monar Paola S.^ORCID,Sanabria María R.,Alonso-Tarancon Ana M.,Coco-Martin Rosa M.,Mayo-Iscar Agustín

Funder

Gerencia Regional de Salud de Castilla-León

Spanish Ministerio de Economía y Competitividad

Consejería de Educación de la Junta de Castilla y León and FEDER

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Link

https://link.springer.com/content/pdf/10.1007/s40266-022-00937-y.pdf

Reference42 articles.

1. Kaplan RS, Jehi L, Ko CY, Pusic A, Witkowski M. Health care measurements that improve patient outcomes. NEJM Catal Innov Care Deliv. 2021. https://doi.org/10.1056/CAT.20.0527.

2. Patient Engagement: Technical Series on Safer Primary Care. Licence: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization; 2016. https://apps.who.int/iris/bitstream/handle/10665/252269/9789241511629-eng.pdf. Accessed 29 Dec 2021.

3. American Academy of Ophthalmology. Age-related macular degeneration PPP-Updated 2019. https://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp. Accessed 29 Dec 2021.

4. Friedman DS, O’Çolmain BJ, Muñoz B, et al. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564–72. https://doi.org/10.1001/archopht.122.4.564.

5. Spanish Eyes Epidemiological (SEE) Study Group. Prevalence of age-related macular degeneration in Spain. Br J Ophthalmol. 2011;95(7):931–6. https://doi.org/10.1136/bjo.2010.187773.